Science Explorer Back to mapMap
Discussion
Company · Louisville · United States

EndoProtech (United States)

endoprotech-inc.business.siteROR OpenAlex
Research works
2
▲ 29% vs 2018-21
Citations
25
13.4 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
55%
world 40%
International
13%
world 18%
EndoProtech (United States)

Not ranked overall: EndoProtech (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does EndoProtech (United States) work in?

In all years, 53% of research at EndoProtech (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (32%), Engineering (11%).

Health Sciences: 1 fractional works · 52.6% of its workMedicine: 1 fractional works · 47.4% of its workNursing: 0 fractional works · 5.3% of its workLife Sciences: 1 fractional works · 36.8% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 31.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 5.3% of its workPhysical Sciences: 0 fractional works · 10.5% of its workEngineering: 0 fractional works · 10.5% of its workALL ITS WORKEndoProtech(United States)2fractional works, all years
Life Sciences37%Physical Sciences11%Health Sciences53%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine147.4%
    2. Nursing05.3%
    1. Biochemistry, Genetics and Molecular Biology131.6%
    2. Pharmacology, Toxicology and Pharmaceutics05.3%
    1. Engineering010.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from EndoProtech (United States)?

The most cited paper from EndoProtech (United States) is "Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench" (Walter E. Rodriguez, Banrida Wahlang, Yali Wang et al., 2019), with 60 citations. Next come "Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration" (17) and "Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis" (11).

Most cited papers
#PaperReleasedCitations
1 Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench Walter E. Rodriguez, Banrida Wahlang, Yali Wang et al. · Hepatology Open access 13 May 2019 60
2 Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration Mohamed Elnagdy, Yali Wang, Walter E. Rodriguez et al. · The Journal of Pathology Open access 21 Sep 2023 17
3 Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis Leila Gobejishvili, Walter E. Rodriguez, Philip Michael Bauer et al. · Drug Design Development and Therapy Open access May 2022 11
4 Rapid Lipid Modification of Endothelial Cell Membranes in Cardiac Ischemia/Reperfusion Injury: a Novel Therapeutic Strategy to Reduce Infarct Size Claudio J. Maldonado, Mai-Dung Nguyen, Phillip Bauer et al. · Cardiovascular Drugs and Therapy Open access 20 Oct 2020 11
5 Stabilizing endothelium of donor hearts with fusogenic liposomes reduces myocardial injury and dysfunction Tathyana Fensterer, William Brent Keeling, Phani K. Patibandla et al. · Journal of Surgical Research Open access 30 Oct 2012 4
All 6 most cited papers, with filters and sorting

Which research topics does EndoProtech (United States) publish most on?

By volume in 2022-now: Phosphodiesterase function and regulation, Liver physiology and pathology, Liver Disease and Transplantation and Nausea and vomiting management.

Phosphodiesterase functi…0Phosphodiesterase function and regulation: 0 fractional worksLiver physiology and pathology: 0 fractional worksLiver Disease and Transplantation: 0 fractional worksNausea and vomiting management: 0 fractional worksGastrointestinal motility and disorders: 0 fractional works
Molecular BiologyHepatologySurgeryGastroenterology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Phosphodiesterase function and regulation Molecular Biology 0 works
  2. 2 Liver physiology and pathology Hepatology 0 works
  3. 3 Liver Disease and Transplantation Hepatology 0 works
  4. 4 Nausea and vomiting management Surgery 0 works
  5. 5 Gastrointestinal motility and disorders Gastroenterology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.4%not open44.6%

World: 40% of research is openly available.

with international co-authors13.4%domestic only86.6%

World: 18% is written across borders.

How has EndoProtech (United States)'s research output changed?

Output in 2022-2025 was 29% higher than in 2018-2021.

20152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Louisville

All research institutions in Louisville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about EndoProtech (United States). Posts are plain text and can be reported.